BioAdvance News

Immunome Announces Pricing of Upsized Initial Public Offering

By WebmasterOctober 1, 2020November 1st, 2024No Comments

Immunome Announces Pricing of Upsized Initial Public Offering

Previous PostImmunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering
Next PostAnnovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease